RT @MedicalEvidence: Framing the conversation - use of @PRECIS_2 ratings to advance understanding of pragmatic trial design domains via #Tr…
RT @charlesweijer: Using #PRECIS-2 to advance discussions about the #design of #pragmatic #RCTs. @KirstyLoudon @PRECIS_2 @PCORI @MedicalEvi…
"RT charlesweijer: Using #PRECIS-2 to advance discussions about the #design of #pragmatic #RCTs. KirstyLoudon PRECIS_2 PCORI MedicalEvidence https://t.co/lVeI7gNdaO https://t.co/gRIinrnhTq"
RT @charlesweijer: Using #PRECIS-2 to advance discussions about the #design of #pragmatic #RCTs. @KirstyLoudon @PRECIS_2 @PCORI @MedicalEvi…
RT @MedicalEvidence: Framing the conversation - use of @PRECIS_2 ratings to advance understanding of pragmatic trial design domains via #Tr…
RT @MedicalEvidence: There has been a +ve response to using @PRECIS_2 to guide conversations around trial design: https://t.co/mBNtu9IjVS #…
There has been a +ve response to using @PRECIS_2 to guide conversations around trial design: https://t.co/mBNtu9IjVS #Trialsjournal https://t.co/0Hhe7ec9jZ
RT @MedicalEvidence: Framing the conversation - use of @PRECIS_2 ratings to advance understanding of pragmatic trial design domains via #Tr…
RT @charlesweijer: Using #PRECIS-2 to advance discussions about the #design of #pragmatic #RCTs. @KirstyLoudon @PRECIS_2 @PCORI @MedicalEvi…
RT @MedicalEvidence: Framing the conversation - use of @PRECIS_2 ratings to advance understanding of pragmatic trial design domains via #Tr…
Framing the conversation - use of @PRECIS_2 ratings to advance understanding of pragmatic trial design domains via #Trialsjournal: https://t.co/mBNtu9ZVks @KirstyLoudon
RT @charlesweijer: Using #PRECIS-2 to advance discussions about the #design of #pragmatic #RCTs. @KirstyLoudon @PRECIS_2 @PCORI @MedicalEvi…
RT @charlesweijer: Using #PRECIS-2 to advance discussions about the #design of #pragmatic #RCTs. @KirstyLoudon @PRECIS_2 @PCORI @MedicalEvi…
RT @charlesweijer: Using #PRECIS-2 to advance discussions about the #design of #pragmatic #RCTs. @KirstyLoudon @PRECIS_2 @PCORI @MedicalEvi…
Using #PRECIS-2 to advance discussions about the #design of #pragmatic #RCTs. @KirstyLoudon @PRECIS_2 @PCORI @MedicalEvidence https://t.co/937sJQ1mtR https://t.co/9qf8q5OEs7